<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2026 21_1-2_20</article-id>
<article-id pub-id-type="doi">10.15836/ccar2026.20</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
<subj-group subj-group-type="subheading"><subject>Coronary heart disease and complex PCI procedures</subject></subj-group>
</article-categories>
<title-group>
<article-title>Through the thorny paths of invasive cardiology &#x2013; complex high-risk percutaneous intervention supported by the Impella system: a case report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4745-1066</contrib-id><name><surname>Tuli&#x010D;i&#x0107;-Mihel&#x010D;i&#x0107;</surname><given-names>Alenka</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6323-462X</contrib-id><name><surname>Valen&#x010D;ak</surname><given-names>Renata</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-8893-6365</contrib-id><name><surname>Prese&#x017E;nik</surname><given-names>Sa&#x0161;a</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8717-0357</contrib-id><name><surname>Stankovi&#x0107;</surname><given-names>Marina</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-3820-9021</contrib-id><name><surname>&#x010C;izmi&#x0107;</surname><given-names>Mato</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6188-0708</contrib-id><name><surname>Cvitku&#x0161;i&#x0107; Lukenda</surname><given-names>Katica</given-names></name></contrib>
<aff id="aff1"><institution>General Hospital &#x201D;Dr Josip Ben&#x010D;evi&#x0107;&#x201D;, Slavonski Brod</institution>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Alenka Tuli&#x010D;i&#x0107;-Mihel&#x010D;i&#x0107;, Op&#x0107;a bolnica &#x201D;Dr Josip Ben&#x010D;evi&#x0107;&#x201D;, Andrije &#x0160;tampara 42, HR-35000 Slavonski Brod, Croatia. / Phone: +385-98-771-551 / E-mail: <email xlink:href="alenkaveyron@gmail.com">alenkaveyron@gmail.com</email></corresp></author-notes>
<pub-date date-type="pub" publication-format="electronic"><month>12</month><year>2025</year></pub-date>
<pub-date date-type="pub" publication-format="print"><month>12</month><year>2025</year></pub-date>
<volume>21</volume>
<issue>1-2</issue>
<fpage>20</fpage>
<lpage>20</lpage>
<history>
<date date-type="received"><day>18</day><month>10</month><year>2025</year></date>
<date><day>14</day><month>11</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>Croatian Cardiac Society</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>complex coronary intervention</kwd><kwd>rotational atherectomy</kwd><kwd>nursing education</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction</bold>: The purpose of this case report is to demonstrate the complexity of percutaneous coronary interventions, the role of the Impella heart pump in providing adequate hemodynamic support, and the importance of the preparedness and education of all team members to successfully perform such high-risk and demanding procedures (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>).</p>
<p><bold>Case report</bold>: 77-year-old patient with significant comorbidities and multiple malignancies in remission underwent coronary angiography, which revealed multivessel disease &#x2013; a chronic total occlusion (CTO) of the right coronary artery, 70% stenosis of the left main (LM) coronary artery, 90% stenosis of the left anterior descending artery (LAD), and diffuse changes in all coronary vessels. Due to significant comorbidities and extremely high surgical risk, the cardiac surgeon did not recommend surgical revascularization. The interventional cardiologists in our department decided to proceed with percutaneous coronary intervention (PCI) supported by the Impella system, as the patient already showed signs of hemodynamic instability during the angiography itself. Since the patient also had peripheral vascular disease, percutaneous transluminal angioplasty (PTA) and balloon dilatation of the femoral artery were first performed to allow placement of the Impella CP system into the left ventricle. Lesion preparation was carried out using rotational atherectomy, cutting and scoring balloons, and Shockwave intravascular lithotripsy (IVL). Intravascular ultrasound (IVUS) confirmed adequate lesion preparation, and two stents were implanted &#x2013; distally 3.0x28 mm and proximally 3.5x44 mm &#x2013; optimized by post-dilatation. Good stent expansion and apposition were confirmed by final IVUS, after which the Impella system was removed. Hemostasis was achieved using two Prostyle and one AngioSeal vascular closure device.</p>
<p><bold>Conclusion</bold>: The patient was discharged home with stable vital signs, hemodynamically and cardiopulmonary compensated. Four months later, during a follow-up examination, he reported feeling well, without chest pain, and with optimal vital parameters.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonton</surname><given-names>C</given-names></name><name><surname>Thompson</surname><given-names>C</given-names></name><name><surname>Wollmuth</surname><given-names>JR</given-names></name><name><surname>Morris</surname><given-names>DL</given-names></name><name><surname>Dahle</surname><given-names>TG</given-names></name></person-group>. <article-title>The Role of Hemodynamic Support in High-risk Percutaneous Coronary Intervention.</article-title> <source>US Cardiology Review.</source> <year>2020</year>;<volume>14</volume>:<elocation-id>e13</elocation-id>. <pub-id pub-id-type="doi">10.15420/usc.2020.18</pub-id><pub-id pub-id-type="pmid">39720455</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
